Skip to Content

  • Search

View Additional Section Content

HCRI-DAPT A prospective, multi-center, randomized, double-blind trial to assess the effectiveness and safety of 12 versus 30 months of dual antiplatelet therapy (DAPT) in subjects undergoing percutaneous coronary intervention (PCI) with either drug-eluting stent (DES) or bare metal stent (BMS) placement for the treatment of coronary artery lesions.

Principal Investigator(s)
Robert A. Watson, III, M.D.
Asoka Balaratna, M.D. (Sub-Investigator)
Marc C. Cohen, M.D. (Sub-Investigator)
Peter B. Frechie, D.O. (Sub-Investigator)
Bruce D. Klugherz, M.D. (Sub-Investigator)

Clinical Trial Categories

  • Cardiology
Matthew G. Dreese, MS at 215-481-4193


  • Abington Medical Specialists

Find a Physician
Search Our Directory


Schedule a Test
Request an Appointment


Clinical Trials Details